
PharmaCyte Biotech
PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as “Cell-in-a-Box®.
Market cap
$6.7m
Enterprise value
($9m)
Share price
$0.96 PMCB
Recent deals
Authorizing premium user...